Muhammad Arba - researchr alias

researchr

You are not signed in
Sign in
Sign up

Viewing Publication 1 - 6 from 6

2022

Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulationsDhrumi C. Patel, Katherine R. Hausman, Muhammad Arba, Annie Tran, Phillip M. Lakernick, Chun Wu. cbm, 140:105084, 2022. [doi]

2021

Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2Muhammad Arba, Setyanto Tri Wahyudi, Dylan J. Brunt, Nicholas Paradis, Chun Wu. cbm, 129:104156, 2021. [doi]

2018

Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasomeMuhammad Arba, Andry Nur-Hidayat, Slamet Ibrahim Surantaadmaja, Daryono Hadi Tjahjono. CANDC, 77:64-71, 2018. [doi]

Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasomeMuhammad Arba, Andry Nur-Hidayat, Ruslin, Muhammad Yusuf, Sumarlin, Rukman Hertadi, Setyanto Tri Wahyudi, Slamet Ibrahim Surantaadmaja, Daryono Hadi Tjahjono. CANDC, 74:230-238, 2018. [doi]

2017

In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitorMuhammad Arba, Sunandar Ihsan, La Ode Ahmad Nur Ramadhan, Daryono Hadi Tjahjono. CANDC, 67:9-14, 2017. [doi]

Molecular modeling of cationic porphyrin-anthraquinone hybrids as DNA topoisomerase IIβ inhibitorsMuhammad Arba, Ruslin, Sunandar Ihsan, Setyanto Tri Wahyudi, Daryono Hadi Tjahjono. CANDC, 71:129-135, 2017. [doi]

Sign in or sign up to see more results.

runs on WebDSL